COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Loss Contingencies [Line Items] | |||
| Royalties percentage | 16.00% | ||
| Contingency liability | $ 2,500 | $ 2,400 | |
| Royalty interest rate description | The Company is committed to pay royalties to the Israeli Government at a rate of 3% to 5% of the sales of its product, up to 100% of the amount of the grants received plus annual interest, as such term is defined under the IIA’s rules and guidelines. | ||
| Contingent research and development | $ 0 | 20 | $ 100 |
| Royalty expenses | 20 | 100 | 100 |
| Payments for fund | 900 | ||
| Collaborative assets acquisition | 300 | 500 | |
| Sales and marketing expenses | $ 0 | $ 300 | $ 200 |
| Minimum [Member] | |||
| Loss Contingencies [Line Items] | |||
| Payment of royalty percentage sales | 1.50% | ||
| Maximum [Member] | |||
| Loss Contingencies [Line Items] | |||
| Payment of royalty percentage sales | 2.00% | ||
| BIRD Foundation [Member] | |||
| Loss Contingencies [Line Items] | |||
| Development costs | 50.00% | ||
| Royalty interest rate description | The Company is committed to pay royalties to BIRD at a rate of 5% of the sales of its product, up to 113% if full repayment is made by April 2025, 125% if full repayment is made by April 2026, 138% if full repayment is made by April 2027, and 150% if full repayment is made after April 2027. | ||